PRESS RELEASE published on 11/19/2024 at 07:30, 1 year 8 months ago Inside Information / Other news releases AFYREN awarded Silver Medal by EcoVadis with an improved score, recognized for sustainability efforts in greentech industry Sustainability EcoVadis Silver Medal GreenTech AFYREN
PRESS RELEASE published on 11/19/2024 at 07:30, 1 year 8 months ago Informations privilégiées / Autres communiqués AFYREN obtient la médaille d’argent ECOVADIS avec un score en progression, se positionne parmi le top 15% des entreprises évaluées et améliore sa notation RSE. Communiqué de presse AFYREN EcoVadis RSE Durabilité AFYREN Médaille D'argent
PRESS RELEASE published on 09/30/2024 at 10:17, 1 year 10 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 09/30/2024 at 07:35, 1 year 10 months ago AFYREN publie ses résultats financiers semestriels 2024 Résultats Financiers Partenariats Stratégiques Trésorerie Production Durable AFYREN NEOXY
BRIEF published on 09/30/2024 at 07:35, 1 year 10 months ago AFYREN publishes its 2024 half-year financial results Financial Results Strategic Partnerships Treasury Sustainable Production AFYREN NEOXY
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 10 months ago Informations privilégiées / Communiqué sur comptes, résultats AFYREN annonce ses résultats financiers semestriels 2024, avec des ajustements opérationnels pour atteindre la production en continu d'AFYREN NEOXY. Solide assise financière et avancées commerciales marquantes Résultats Financiers Partenariats Commerciaux Ajustements Opérationnels AFYREN Production En Continu
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 10 months ago Inside Information / News release on accounts, results AFYREN announces its 2024 half-year financial results, highlighting adjustments needed for continuous production of AFYREN NEOXY products. Solid financial base supports operations with €43 million in cash as of June 2024 Cash Position Financial Base AFYREN Continuous Production 2024 Half-year Financial Results
BRIEF published on 08/29/2024 at 07:50, 1 year 11 months ago AFYREN Signs Multi-Year Contract with US Nutraceutical Manufacturer Sustainability GreenTech Nutraceuticals AFYREN Bio-based Ingredients
BRIEF published on 08/29/2024 at 07:50, 1 year 11 months ago AFYREN signe un contrat pluriannuel avec un fabricant américain de produits nutraceutiques Durabilité Technologie Verte Nutraceutiques AFYREN Ingrédients Biosourcés
PRESS RELEASE published on 08/29/2024 at 07:45, 1 year 11 months ago Inside Information / Other news releases AFYREN signs multi-year commercial contract with US nutraceutical company for bio-based acids, tapping into fast-growing market. Contract underscores focus on natural, sustainable solutions for health & well-being Sustainable Solutions Nutraceuticals AFYREN Commercial Contract Bio-based Acids
Published on 08/07/2026 at 23:15, 2 days 8 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 8 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 8 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 9 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 07:00, 17 minutes ago Infracore SA announces partial exercise of the over-allotment option
Published on 08/10/2026 at 07:00, 17 minutes ago Infracore SA annonce l’exercice partiel de l’option de surallocation
Published on 08/10/2026 at 07:00, 17 minutes ago MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
Published on 08/10/2026 at 07:00, 17 minutes ago ARYZTA protects profitability in a demanding environment; Capital returns to resume in 2027; Reviewing all options for Germany
Published on 08/10/2026 at 07:00, 17 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 17 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Published on 08/07/2026 at 18:54, 2 days 12 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 12 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 12 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
